This summary covers recent health news, including stable pig prices in Germany, investor focus on AstraZeneca's China probe, ...

In a report released today, Emily Field from Barclays maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price target of ...

A revival in AstraZeneca Plc shares faces a key test this week, with more likely to hinge on the drugmaker’s ability to ...

Company has Price Waterhouse & Co Chartered Accountants LLP as its auditors. As on 31-12-2024, the company has a total of 2.50 Crore shares outstanding.AstraZeneca Share Price Today is Rs. 7410.30. On ...

AstraZeneca Pharma India (APIL) was incorporated on July 11 1979. The Company is engaged in the business of manufacture distribution and marketing of pharmaceutical products and co-ordinates clinical ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In a report released today, James Gordon from J.P. Morgan maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price target ...

AstraZeneca is a leader in cancer treatments with FDA-approved drugs. Read why AZN stock is still a 'Buy' and why the company’s future looks bright.